Submission Details
| 510(k) Number | K123532 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 16, 2012 |
| Decision Date | December 14, 2012 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K123532 is an FDA 510(k) clearance for the OCELOT PIXL CATHETER, a Catheter For Crossing Total Occlusions (Class II — Special Controls, product code PDU), submitted by Avinger, Inc. (Redwood City, US). The FDA issued a Cleared decision on December 14, 2012, 28 days after receiving the submission on November 16, 2012. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1250.
| 510(k) Number | K123532 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 16, 2012 |
| Decision Date | December 14, 2012 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | PDU — Catheter For Crossing Total Occlusions |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1250 |
| Definition | To Facilitate The Intraluminal Placement Of Conventional Guidewires Beyond Stenotic Lesions (including Subchronic And Chronic Total Occlusions) In The Peripheral Vasculature Prior To Further Percutaneous Intervention, Such As Angioplasty, Atherectomy Or Stent Placement. |